Elise Tabin is an award-winning beauty journalist, editor, and expert with 20 years of experience
Patients see a visible reduction in fat volume while preserving surrounding tissue
Reviews and overviews consistently describe it as a multi-receptor peptide being studied for obesity and metabolic control, with a receptor profile broader than earlier incretin agents
PT-141 is any pharmaceutically acceptable salt form, and is formulated in any pharmaceutically acceptable aqueous solution, the aqueous solution optionally including one or more salts, such as sodium chloride, one or more acids, such as citric acid, and one or more additional ingredients, including cellulose or derivatives thereof, saccharides or polysaccharides such as dextrose, and any of a wide variety of surfactants, chelating agents and preservatives
No significant differences were observed in achieving LDL-cholesterol targets, although tirzepatide was superior in attaining triglyceride goals
Of note, a study by Boileau et al